Company Filing History:
Years Active: 2018-2019
Title: Suneela Prodduturi: Innovator in Pharmaceutical Engineering
Introduction
Suneela Prodduturi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical engineering, particularly in the development of innovative extruder technologies. With a focus on enhancing oral dosage forms, Suneela has been instrumental in advancing the efficiency and effectiveness of pharmaceutical manufacturing processes.
Latest Patents
Suneela Prodduturi holds 2 patents, with his latest invention being a hot melt fragmentation extruder and process. This invention features a co-rotating twin screw extruder designed for forming fragments. The extruder includes an intake zone for receiving one or more excipients suitable for oral dosage, along with one or more active pharmaceutical ingredients. It also has a melt zone for softening at least one excipient to create a viscous mass or melt. Furthermore, the fragmenting zone is responsible for fragmenting and cooling the viscous mass into cooled fragments, which are then recovered through the extruder outlet.
Career Highlights
Suneela Prodduturi is currently associated with Steerlife India Private Limited, where he continues to innovate and develop new technologies in the pharmaceutical sector. His work has been pivotal in improving the manufacturing processes of oral dosage forms, making them more efficient and reliable.
Collaborations
Suneela has collaborated with several professionals in his field, including Babu Padmanabhan and Himadri Sen. These collaborations have fostered a creative environment that encourages the exchange of ideas and advancements in pharmaceutical engineering.
Conclusion
Suneela Prodduturi's contributions to the field of pharmaceutical engineering through his innovative patents and collaborative efforts highlight his commitment to improving drug manufacturing processes. His work continues to influence the industry positively, paving the way for future advancements.